澳门银银河官方网站在线登录(VIP认证)-Best Platform

EN

Company Profile

Learn more

Adhering to the vision of "innovation for the great majority", Qyuns Therapeutics focuses on R & D, industrialization and commercialization of antibody drugs for autoimmune and allergic diseases, and strives to improve drug accessibility and affordability.

  • Founded in

    20152015
  • Stock Code

    2509. HK2509. HK
  • Pipelines

    99
  • IND Approved

    1919
  • Patent Declared

    9090+

Integrated industrial capability

Innovation and Integration

We have the develop capability to cover full life cycle from discovery to commercialization of antibody drugs

Pipeline

  • Drug
  • Target
  • Indication
  • Phase
  • BLA
  • Collaboration
PreclinicalPhase IPhase IIPhase III
QX002N
TargetIL-17A
Indication
PhasePreclinicalPhase IPhase IIPhase III
AS
LN
view more
QX005N
TargetIL-4Rα
Indication
PhasePreclinicalPhase IPhase IIPhase III
moderate-to-severeAD
PN
CRSwNP
CSU
moderate-to-severe asthma
COPD
adolescent AD
view more
QX001S
TargetIL-12/IL-23p40
Indication
PhasePreclinicalPhase IPhase IIPhase III
moderate-to-severe plaque Ps
UC/CD
view more
QX004N
TargetIL-23p19
Indication
PhasePreclinicalPhase IPhase IIPhase III
Ps
CD
view more
QX006N
TargetIFNAR1
Indication
PhasePreclinicalPhase IPhase IIPhase III
SLE
view more
QX008N
TargetTSLP
Indication
PhasePreclinicalPhase IPhase IIPhase III
asthma
moderate-to-severe COPD
severe asthma
view more
QX007N
TargetIL-33
Indication
PhasePreclinicalPhase IPhase IIPhase III
asthma
COPD
view more
QX013N
Targetc-kit
Indication
PhasePreclinicalPhase IPhase IIPhase III
CSU
view more
QX010N
TargetIL-31R
Indication
PhasePreclinicalPhase IPhase IIPhase III
pruritus
view more

AD: atopic dermatitis

CRSwNP: chronic rhinosinusitis with nasal polyps

Ps: psoriasis

AS: ankylosing spondylitis

CSU: chronic spontaneous urticaria

SLE: systemic lupus erythematosus

CD: Crohn’s disease

LN: lupus nephritis

UC: ulcerative colitis

COPD: chronic obstructive pulmonary disease

PN: prurigo nodularis

IFNAR1: interferon-alpha/beta receptor subunit 1

IL-4Rα interleukin-4 receptor subunitα

IL-12/IL-23p40: interleukin-12/interleukin-23 subunit p40

IL-17A: interleukin-17A

IL-23p19: interleukin-23 subunit p19

IL-31R: interleukin-31 receptor

IL-33: interleukin-33

TSLP: thymic stromal lymphopoietin


​Pipeline updated to 2023-10-30

Collaboration

News Center

XML 地图